Metabolic changes detected in vivo by 1H MRS in the MPTP-intoxicated mouse

NMR in Biomedicine

Volumn 23, Issue 6, 2010, Pages 547-553

  Chassain, Carine ^a,b,c   Bielicki, Guy ^b   Keller, Cécile ^b   Renou, Jean Pierre ^b   Durif, Franck ^a,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UR370 QuaPA   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Cortex; GABA; Glutamate; Glutamine; Levodopa; Magnetic resonance spectroscopy; MPTP intoxicated mice; Striatum

Indexed keywords

ANIMALS; BIOMOLECULES; FUZZY CONTROL; MAGNETIC MATERIALS; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; METABOLITES; ORGANIC ACIDS; PARTICLE DETECTORS;

BEFORE AND AFTER; CEREBRAL CORTEX; CORTEX; DENERVATION; EXCITATORY AMINO ACIDS; IN-VIVO; LEVODOPA; METABOLIC CHANGES; METABOLITE LEVEL; STRIATUM;

AMINO ACIDS;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; LEVODOPA; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROTOXIN; PROTON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ANATOMY AND HISTOLOGY; ANIMAL; BRAIN; C57BL MOUSE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; DOPAMINE; DOPAMINE AGENTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; LEVODOPA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; NEUROTOXINS; PROTONS;

EID: 77955108549     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1504     Document Type: Article

References (44)

1. Nagatsu T, Sawada M. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J. Neural. Transm. Suppl. 2007; 72: 113-120.
2. Rascol O, Sabatini U, Chollet F, Fabre N, Senard JM, Montastruc JL, Celsis P, Marc-Vergnes JP, Rascol A. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J. Neurol. Neurosurg. Psychiatry. 1994; 57: 567-571.
3. Eidelberg D, Edwards C. Functional brain imaging of movement disorders. Neurol. Res. 2000; 22: 305-312.
4. Hirsch EC, Perier C, Orieux G, Francois C, Feger J, Yelnik J, Vila M, Levy R, Tolosa ES, Marin C, Trinidad Herrero M, Obeso JA, Agid Y. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci. 2000; 23: S78-85.
5. Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J. Anat. 2000; 196: 527-542.
6. Gerfen RR. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 1989; 246: 385-388.
7. Nieuwenhuys R. The neocortex. An overview of its evolutionary development, structural organization and synaptology. Anat. Embryol. 1994; 190: 307-337.
8. Anglade P, Mouatt-Prigent A, Agid Y, Hirsch E. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration. 1996; 5: 121-128. (Pubitemid 26248601)
9. Ingham CA, Hood SH, Taggart P, Arbuthnott GW. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J. Neurosci. 1998; 18: 4732-4743.
10. Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF. Time-dependent changes in striatal glutamate sysnpses following a 6-hydroxydopamine lesion. Neuroscience. 1999; 88: 1-16.
11. Jonkers N, Sarre S, Ebinger G, Michotte Y. MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats. Brain Res. 2002; 926: 149-155. (Pubitemid 34117600)
12. Chassain C, Bielicki G, Durand E, Lolignier S, Essafi F, Traoré A, Durif F. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse. J. Neurochem. 2008; 105: 874-882.
13. Rascol O, Sabatini U, Chollet F, Celsis P, Montastruc JL, Marc-Vergnes JP, Rascol A. Supplementary and primary sensorimotor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch. Neurol. 1992; 49: 144-148.
14. Samuel M, Ceballos-Baumann AO, Blin J, Uema T, Boecker H, Passingham RE, Brooks DJ. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain. 1997; 120: 963-976.
15. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L, Berry I, Montastruc JL, Chollet F, Rascol O. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain. 2000; 123: 394-403.
16. Haslinger B, Erhard P, Kämpfe N, Boecker H, Rummeny E, Schwaiger M, Conrad B, Ceballos-Baumann AO. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain. 2001; 121: 558-570. (Pubitemid 32221323)
17. Mallol R, Barros-Loscertales A, Lopez M, Belloch V, Parcet MA, Avila C. Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Res. 2007; 1147: 265-271.
18. 1H NMR Spectroscopy in the human visual cortex. J. Cereb. Blood Flow Metab. 2006; 27: 1055-1063.
19. Mangia s, Giove F, Tkac I, Logethetis NK, Henry PG, Olman CA, Maraviglia B, Di Salle F, Ugurbil K. Metabolic and hemodynamic events after changes in neuronal activity: current hypothesis, theoretical predictions and in vivo NME experimental findings. J. Cereb. Blood Flow Metab. 2009; 29: 441-463.
20. Monaca C, Laloux C, Jacquesson JM, Gele P, Marechal X, Bordet R, Destee A, Derambure P. Vigilance states in a parkinsonian model, the MPTP mouse. Eur. J. Neurosci. 2004; 20: 2474-2478.
21. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: New York, 2001.
22. Tkac I, Henry PG, Andersen P, Keene CD, Low WC, Gruetter R. Highly resolved in vivo 1H spectroscopy of the mouse brain at 9.4T. MRM. 2004; 52: 478-484. (Pubitemid 39108958)
23. 1H NMR spectrum of rat brain. Magn. Reson. Med. 1993; 30: 38-44.
24. Pfeuffer J, Tkác I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in shortecho- time (1)H NMR spectra of the rat brain. J. Magn. Reson. 1999; 141: 104-120.
25. Valette J, Guillermier M, Besret L, Boumezbeur F, Hantraye P, Lebon V. Optimized diffusion-weighted spectroscopy for measuring brain glutamate apparent diffusion coefficient on a whole-body MR system. NMR Biomed. 2005; 18: 527-533.
26. Xin L, Gambarota G, Mlynarik V, Gruetter R. Proton T2 relaxation time of J-coupled cerebral metabolites in rat brain at 9.4T. NMR in Biomed 2008; 21: 396-401. 27.
27. Larvaron P, Bielicki G. Boespflug-Tanguy o, Renou JP. Proton MRS of early post-natal mouse brain modifications in vivo. NMR Biomed. 2006; 19: 180-187.
28. Agrawal HC, Davis JM, Himwich WA. Develop mental changes in mouse brain: weight, water content, and free amino acids. J Neurochem. 1968; 15: 917-923.
29. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. The FASEB. 2004; 18: 1291-1293. (Pubitemid 39561580)
30. Chassain C, Bielicki G, Donnat JP, Renou JP, Eschalier A, Durif F. Cerebral glutamate metabolism in Parkinson's disease: an in vivo dynamic 13C NMS study in the rat. Exp. Neurol. 2005; 191: 276-284.
31. Thompson RB, Allen PS. Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification. MRM. 1999; 41: 1162-1169.
32. Thompson RB, Allen PS. Response of metabolites with coupled spins to the STEAM sequence. MRM. 2001; 45: 955-965. 33.
33. Gerfen CR. Synaptic organization of the striatum. J. Electron. Microsc. Tech. 1988; 10: 265-281.
34. Di Chiara G, Morelli M, Consolo S. Modulatory functions of neurotransmittors in the striatum: ACh/DA/NMDA interactions. Trends Neurosci. 1994; 17: 228-233.
35. Corsi C, Pinna A, Gianfriddo M, Melani A, Morelli M, Pedata F. Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. Eur. J. Pharmacol. 2003; 464: 33-38.
36. Robelet S, Melon C, Guillet B, Salin P, Kerkerian-Le Goff L. Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur. J. Neurosci. 2004; 20: 1255-1266.
37. McKenna MC, Stevenson JH, Huang X, Hopkins IB. Differential distribution of the enzymes glutamate dehydrogenase and aspartate aminotransferase in cortical synaptic mitochondria contributes to metabolic compartmentation in cortical synaptic terminals. Neurochem. Int. 2000; 37: 229-241.
38. Brownell AL, Canales K, Chen I, Jenkins BG, Owen C, Livni E, Yu M, Cicchetti F, Sanchez-Pernaute R, Isacson O. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. NeuroImage 2003; 20: 1064-1075.
39. Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhenced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6- tetrahydroxypiridine primate model of Parkinson's disease. J. Neurosci. 2002; 22: 4639-4653.
40. Escola L, Michelet T, Douillard G, Guehl D, Bioulac B, Burbaud P. Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Ann. Neurol. 2002; 52: 581-587.
41. Escola L, Michelet T, Macia F, Guehl D, Bioulac B, Burbaud P. Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia? Brain. 2003; 126: 95-114.
42. Nicholas AP. Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine. Mov. Disord. 2006; 22: 99-104.
43. Nicholas AP, Buck K, Ferger B. Effect of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity. Neurosci. Lett. 2008; 443: 204-208.
44. Holmer HK, Keyghobadi M, Moore C, Meshul CK. L-dopa-induced reversal in striatal glutamate partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 2005; 136: 333-341.